![]() |
市場調查報告書
商品編碼
1380383
全球醫療設備連接市場 2023-2030Global Medical Devices Connectivity Market 2023-2030 |
預計全球醫療設備連接市場在預測期內複合CAGR將達到 18.5%。醫療保健基礎設施的數位化不斷發展、醫療保健環境中物聯網醫療設備的高度整合以及對聯網醫療設備的高需求是推動全球醫療設備連接市場成長的關鍵因素。電子病歷和健康資訊交換系統的不斷實施以及對遠距醫療技術的高需求進一步促進了市場的成長。據 HealthIT.Gov 稱,截至 2021 年,近五分之四的辦公室醫生 (78%) 和幾乎所有非聯邦急診醫院 (96%) 採用了經過認證的 EHR。這標誌著自 2016 年以來 10 年來的巨大進步,當時 96% 的醫院和 78% 的醫生採用了 EHR。
主要市場參與者積極參與新產品發布和合作,以擴大其在市場上的影響力。例如,2021 年 10 月,皇家飛利浦推出了支援整合和互通性的設備驅動程式—飛利浦膠囊醫療設備資訊平台 (MDIP)。飛利浦 Capsule MDIP 整合到飛利浦 HealthSuite 平台中,安裝在全球 3,000 多個醫療機構中。飛利浦 Capsule MDIP 捕獲流式臨床資料並將其轉化為患者護理管理的可行見解,旨在改善護理團隊之間的協作、簡化臨床工作流程並提高生產力。這種持續的市場發展正在促進全球市場的成長。然而,連接解決方案的高成本限制了全球醫療設備連接市場的成長。 5G 技術在醫療設備連接服務中的持續應用預計將為市場成長提供利潤豐厚的機會。
Title: Global Medical Devices Connectivity Market Size, Share & Trends Analysis Report, By Component (Solution, Services) By Technology (Wired, Wireless, Hybrid), By End-User (Hospitals, Ambulatory Care Centers, Other),Forecast Period (2023-2030).
The global medical devices connectivity market is anticipated to grow at a significant CAGR of 18.5% during the forecast period. The growing digitalization of healthcare infrastructure, high integration og IoT medical devices in healthcare settings, and high demand for connected medical devices is a key factor driving the growth of the global medical device's connectivity market. The rising implementation of EHRs and health information exchange systems along with the high demand for telemedicine technologies is further contributing to the market growth. According to HealthIT.Gov, as of 2021, nearly 4 in 5 office-based physicians (78%) and nearly all non-federal acute care hospitals (96%) adopted a certified EHR. This marks substantial 10-year progress since 2016 when 96% of hospitals and 78% of physicians had adopted an EHR.
The key market players are actively involved in new product launches and collaborations to expand their presence in the market. For instance, in October 2021, Royal Philips launched device drivers that enable integration and interoperability, Philips Capsule Medical Device Information Platform (MDIP). Philips Capsule MDIP integrated into the Philips HealthSuite Platform, installed in more than 3,000 healthcare facilities globally. Philips Capsule MDIP captures streaming clinical data and transforms it into actionable insights for patient care management, aiming to improve collaboration between care teams, streamline clinical workflows, and increase productivity. Such ongoing market developments are promoting the global market growth. However, the high cost of connectivity solutions restrains the growth of the global medical devices connectivity market. The rising implementation of 5G technologies in the medical device connectivity services is anticipated to offer lucrative opportunities to the market growth.
The global medical devices connectivity market is segmented based on component, technology, and end-user. Based on component, the market is segmented into solution and services. Based on technology, the market is segmented into wired, wireless, and hybrid. Based on end-user, the market is segmented into hospitals, ambulatory care centers, and others.
Hospitals held considerable share in the global medical devices connectivity market based on end-user. The high market share can be attributed to the presence of large patient pool, high purchasing power of hospitals to purchase advanced medical device connectivity solutions, decreasing margins in hospitals, and rising focus on delivery high patient safety with care. Additionally, the high integration remote patient monitoring devices in hospitals for the continuous monitoring of patients is anticipated to drive the growth of this market segment.
The global medical devices connectivity market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America). Among all regions, the Asia-Pacific region is anticipated to grow at a considerable CAGR over the forecast period.
The presence of advanced healthcare IT infrastructure, high penetration of connected medical devices along with high healthcare expenditure is a key contributor to the high share of the regional market. The presence of key market players across the region that are continuously working towards this segment is further contributing to the regional market growth. For instance, in April 2023, Medical artificial intelligence (AI) solution company Vuno has received a US patent for its AI-based medical image analysis technology. This patent pertains to a technology aimed at simplifying the process of correcting lesion areas identified by medical personnel during the examination of medical images such as X-rays, magnetic resonance imaging scans and computerized tomography (CT) scans in clinical environments.
The major companies serving the global medical devices connectivity market include: Capsule Technologies, Inc., Cerner Corp., Cisco Systems Inc., GE Healthcare, and Infosys Ltd. among others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in October 2022, BD (Becton, Dickinson and Company) a medical technology company, and Biocorp (Paris:ALCOR), a medical device and delivery systems manufacturer based in France have signed an agreement with the aim of using connected technology to track adherence for self-administered drug therapies, like biologics. Biocorp's Injay is a simple and cost-effective connected solution designed to monitor the use of pre-fillable syringes in clinical studies or routine care. Through NFC technology and specific sensors to identify the product, it can confirm a complete injection and easily transfer that information to a smartphone.
Additionally, in June 2021, Max Healthcare, one of the largest healthcare providers in India with over 15 super specialty hospitals, diagnostics and integrated home care services, has launched an artificial intelligence (AI) powered device integrated patient monitoring framework. Max Healthcare has launched the service in collaboration with digital health solutions provider MyHealthcare.